 |
인쇄하기
취소
|
KFDA approves new anticancer drug
The Korea Food and Drug Administration approved a home-grown anticancer medicine CreaVax-RCC developed by Creagene Inc., a local bio-venture company, for sale in the domestic market, the Ministry of Health and Welfare on May 15.
CreaVax-RCC is indicated for the treatment of kidney cancer and has been proven to suppress the progress of cancer cells by 66 percent during the firm's four-year cl...
CreaVax-RCC is indicated for the treatment of kidney cancer and has been proven to suppress the progress of cancer cells by 66 percent during the firm's four-year cl...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.